RxDoctor Payments Data

Mollie Kinard

Family · Olive Branch, MSNPI 1619476652

Payments from drug & device makers

$960in general payments, 2019–2025

Across 54 payments — averaging $17.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$259
  • Novo Nordisk$195
  • AstraZeneca$140
  • AbbVie$128
  • Boehringer Ingelheim$100
  • IBSA Pharma Inc.$40
  • plus $97 from 6 others

What the payments were for

  • Food & beverage$960100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$960 in reported general payments places this provider in the 65th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$45,521
Medicare patients
114
Services billed
1,041

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin82$64,237
JanuviaSitagliptin Phosphate19$19,365
MounjaroTirzepatide12$12,295
FarxigaDapagliflozin Propanediol14$11,063
OzempicSemaglutide11$10,480
Breo ElliptaFluticasone/Vilanterol13$4,774
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$2,122
SynthroidLevothyroxine Sodium27$2,106
ValacyclovirValacyclovir Hcl23$741
Albuterol Sulfate HfaAlbuterol Sulfate40$739
Omeprazole92$708
Valsartan20$598
Metoprolol Succinate36$560
Rosuvastatin Calcium104$523
Losartan Potassium58$474

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$100$64,23782 claims
MerckJanuvia$20$19,36519 claims
Lilly USA, LLCMounjaro$259$12,29512 claims
AstraZenecaFarxiga$140$11,06314 claims
Novo NordiskOzempic$195$10,48011 claims
AbbVieSynthroid$128$2,10627 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,007 family providers in Mississippi.

Other family in Olive Branch

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →